[What is a good marker for better antihypertensive therapy in diabetic patients when coexisting with hypertension]

Nihon Rinsho. 2002 Sep:60 Suppl 9:679-84.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Albuminuria
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Biomarkers
  • Biphenyl Compounds / therapeutic use
  • Captopril / therapeutic use
  • Cardiomegaly / etiology
  • Cardiomegaly / prevention & control
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Clinical Trials as Topic
  • Diabetes Complications*
  • Diabetic Retinopathy / etiology
  • Diabetic Retinopathy / prevention & control
  • Humans
  • Hypertension / complications*
  • Hypertension / drug therapy*
  • Irbesartan
  • Kidney Diseases / etiology
  • Kidney Diseases / prevention & control
  • Losartan / therapeutic use
  • Practice Guidelines as Topic
  • Risk
  • Tetrazoles / therapeutic use

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Biomarkers
  • Biphenyl Compounds
  • Tetrazoles
  • Captopril
  • Irbesartan
  • Losartan